StockData
Grace Therapeutics, Inc. logo

Grace Therapeutics, Inc. (GRCE) income statement

GRCENasdaqPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$1.73+0.00 (0.00%)

Close on Nov 19, 2026Market cap $36.39MP/E –Yield –

Grace Therapeutics, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2026
-11.9%

Financial strength

Current ratio
11.47
Debt to equity
–
Debt to assets
–
Cash to current liabilities
1100.5%

Valuation

P/E ratio
–
Price to sales
–
Price to book
0.75
Dividend yield
–

See a number that looks wrong?